Efficacy Evaluation of an ODF Iron Supplement Vs an Iron Supplement in Capsules in Subjects with Mild Anemia

Inclusion Criteria: * Written informed consent signed prior to inclusion in the study * 18-55 years * Ability to understand the nature and the purpose of the study, including possible risks and side effects * Capability to collaborate with the investigator and meet the requirements of the entire study * Subjects with mild anemia (with WHO hemoglobin values between 11-11.9 g/dl for women and between 11-12.9 g/dl for men) Exclusion Criteria: * Clinically significant abnormalities in the ECG evaluation * Clinically significant abnormal laboratory values indicative of disease * Known allergy or presumed hypersensitivity to the food supplement investigated (iron) and / or to the excipients of the two formulations * History of anaphylaxis from drugs, dietary supplements or allergic reactions in general, which the investigator believed could influence the outcome of the study * Significant history of kidney, liver, gastrointestinal, cardiovascular, respiratory, skin, haematological, endocrine or neurological diseases that may interfere with the purpose of the study * Taking herbal remedies and dietary supplements (including iron supplements, supplements with vitamin C, supplements with folic acid, supplements with vitamin B12, multivitamins) in the 2 weeks prior to the start of the study * Taking corticosteroids, thyroid hormones, antibiotics, antiepileptics * Alcohol abuse * Any clinical condition that in the investigator's judgment is deemed incompatible with study participation * Women who are pregnant or breastfeeding